Antikoagulation und Antidote

Virginie Siguret, Eric Pautas, Isabelle Gouin-Thibault, Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin. Vitamins and Hormones Series. ,vol. 78, pp. 247- 264 ,(2008) , 10.1016/S0083-6729(07)00012-X

Charles V. Pollack, Paul A. Reilly, John Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, Chak-Wah Kam, Jeffrey I. Weitz, Idarucizumab for Dabigatran Reversal The New England Journal of Medicine. ,vol. 373, pp. 511- 520 ,(2015) , 10.1056/NEJMOA1502000

S. Ziemer, von Heymann, J. Koscielny, [Patients with oral anticoagulation--bridging anticoagulation in the perioperative phase]. Hamostaseologie. ,vol. 29, pp. 247- 255 ,(2009) , 10.1055/S-0037-1617035

Niksa Drinkovic, Gerasimos Filippatos, Gilbert Habib, A Pieter Kappetein, Roland Kassab, Gregory YH Lip UK, Neil Moat UK, Georg Nickenig, Catherine M Otto, John Pepper, Nicolo Piazza, Petronella G Pieper, Raphael Rosenhek, Naltin Shuka, Ehud Schwammenthal, Juerg Schwitter, Pilar Tornos Mas, Pedro T Trindade, Thomas Walther, None, Guidelines on the management of valvular heart disease (version 2012) European Heart Journal. ,vol. 33, pp. 2451- 2496 ,(2012) , 10.1093/EURHEARTJ/EHS109

M. Haug, Merkwürdige Geschichten rund um die Entdeckung und Entwicklung herkömmlicher Antithrombotika Phlebologie. ,vol. 43, pp. 93- 98 ,(2014) , 10.12687/PHLEB2179-2-2014

Felix Schiele, Joanne van Ryn, Keith Canada, Corey Newsome, Eliud Sepulveda, John Park, Herbert Nar, Tobias Litzenburger, None, A specific antidote for dabigatran: functional and structural characterization. Blood. ,vol. 121, pp. 3554- 3562 ,(2013) , 10.1182/BLOOD-2012-11-468207

Genmin Lu, Francis R DeGuzman, Stanley J Hollenbach, Mark J Karbarz, Keith Abe, Gail Lee, Peng Luan, Athiwat Hutchaleelaha, Mayuko Inagaki, Pamela B Conley, David R Phillips, Uma Sinha, A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa Nature Medicine. ,vol. 19, pp. 446- 451 ,(2013) , 10.1038/NM.3102

Robert G. Hart, John W. Eikelboom, Alistair J. Ingram, Charles A. Herzog, Anticoagulants in atrial fibrillation patients with chronic kidney disease Nature Reviews Nephrology. ,vol. 8, pp. 569- 578 ,(2012) , 10.1038/NRNEPH.2012.160

U. Harbrecht, Old and new anticoagulants Hamostaseologie. ,vol. 31, pp. 21- 27 ,(2011) , 10.5482/HA-1149

Viktoria Moschetti, Stephen Norris, Joachim Stangier, Michael Schmohl, Joanne van Ryn, Benjamin Lang, Steven Ramael, Paul Reilly, Stephan Glund, A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran Thrombosis and Haemostasis. ,vol. 113, pp. 943- 951 ,(2015) , 10.1160/TH14-12-1080